American Academy of FertilityCare Professionals Conference, Wichita, USA July 2007
The Annual conference for FertilityCare Professionals was held in Wichita, Kansas this July 2007. This year we had another very worthwhile meeting with presentations from Professor Joe Stanford on the Public Health implications of NaProTechnology Fertility Treatment and a second presentation describing randomized controled clinical trials with regard to reproductive medicine. Dr. Thomas Hilgers gave a critical review of many current concepts in reproductive medicine entitled "Junk Science" which was certainly illuminating. Dr. Phil Boyle presented a Family Physican approach to managing Infertility and Recurrent miscarriage followed by a presentation on progress in using LDN and Dietary strategies to improve fertility treatment. Audio and PowerPoint presentations available HERE.
Chuck Weber was the Banquet speakerand gave an excellent multi-media presentation on the close link between embryonic stem cell research and IVF.
Once again the many FertilityCare Professionals who travelled from all over the world to be there were treated to excellent presentations and inspirational speakers. We are already making plans to attend Rome, Italy from June 9th -13th 2008. We hope to see you there!
American Academy of FertilityCare Professionals CONFERENCE, Albuquerque, USA July 2006
The Annual conference for FertilityCare Professionals was held in Albuquerque, New Mexico this July 2006. This year we gained important new insights regarding the causes of unusual menstrual bleeding as presented by Dr. Thomas Hilgers. The International Institute of Restorative Reproductive Medicine (www.iirrm.org) updated us on most recent developments regarding research efforts into NaProTECHNOLOGY and Professor Joseph Stanford gave an excellent presentation on the Medical, Ethical and Social dimensions of Emergency Contraception.
Dr. Phil Boyle gave a powerpoint presentation on new uses of Low Dose Naltrexone for treating infertility, available HERE.
The powerpoint slides used in the presentation are also available to download HERE (note...this can take a while to download as it is a large file!)
Chuck Weber updated us on the media treatment of fertility issues and gave insights into how we can get the word out about what FertilityCare has to offer instead of the contemporary approach.
American Academy of FertilityCare Professionals CONFERENCE, Florida, USA July 2005
The Annual conference for FertilityCare Professionals was held in St. Petersburg, Florida this July 2005.
The conference was well attended by Doctors and Practitioners from all over the USA, Australia, Canada, UK and Ireland. We were treated to excellent presentations from Dr. Hilgers and Prof. Janet Smith. Tape recordings and a list of all topics covered from the conference are available until 26th August from www.aafcp.org.
NaProTECHNOLOGY CONFERENCE July 2004
A major international conference entitled “Introducing NaProTechnology to the world: Medical Science at the Service of the Human Person” was held in Omaha, Nebraska USA last July (2004). It was a tremendous success. The conference was attended by nearly 400 people, including medical professionals and allied healthcare providers representing 15 different countries. Several couples who have benefited personally from NaProTECHNOLOGY spoke of their experience. One couple were interviewed by reporters and their story was broadcast to over 2 million homes in the USA.
Their interview can be seen at www.saintmaxworldwide.org
Recent Study Links Hormonal contraceptive use with Breast Cancer
The journal of the Mayo Clinic (Mayo Clinic Proceedings) has published a key article in it’s October 2006 issue entitled “Oral Contraceptive Use as a Risk Factor for Pre-menopausal Breast Cancer: A Meta-analysis”, authored by Chris Kahlenborn, M.D., (Internal Medicine, Altoona Hospital, PA), Francesmary
Modugno, Ph.D., (Epidemiology), Douglas M. Potter, Ph.D. (Biostatistics) both from the University of Pittsburgh, and Walter B. Severs, Ph.D., Professor Emeritus of Pharmacology at the Penn State College of Medicine. The major findings from this careful analysis of the world literature were that oral ontraceptives (OCs) were linked with a measurable and statistically significant association with pre-menopausal breast cancer. The risk association was 44% over baseline in parous women (having been pregnant) who took OCs prior to their first pregnancy. For article and graph click here. Full article HERE.
|